Abstract
Endoscopic Resection (ER) is widely considered as the treatment of choice in early Barrett's cancer (EBC) limited to the mucosa. A prerequisite for any endoscopic treatment approach with a curative intent is a very low risk of lymph-node (LN) metastasis of the neoplastic lesion. Surgical series have indicated that there may be a relevant risk of LN metastasis in EBC invading at least the mid third of the submucosa (sm2).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
